FTI-277 trifluoroacetate salt
CAS: 170006-73-2
Rif. 3D-VGA00673
5mg | 1.031,00 € | ||
10mg | 1.350,00 € | ||
25mg | 2.531,00 € | ||
50mg | 4.049,00 € |
Informazioni sul prodotto
- <span class="text-smallcaps">L</span>-Methionine, N-[[5-[(2-amino-3-mercaptopropyl)amino][1,1′-biphenyl]-2-yl]carbonyl]-, methyl ester, (R)-
- <span class="text-smallcaps">L</span>-Methionine, N-[[5-[[(2R)-2-amino-3-mercaptopropyl]amino][1,1′-biphenyl]-2-yl]carbonyl]-, methyl ester
- Methyl[N-[2-Phenyl-4-N-[2(R)-Amino-3-Mercaptopropylamino] Benzoyl]]-Methionate, Tfa
- N-[4-[2(R)-Amino-3-mercaptopropyl]amino-2-phenylbenzoyl]methionine methyl ester trifluoroacetate salt
- L-Methionine, N-[[5-[[(2R)-2-amino-3-mercaptopropyl]amino][1,1′-biphenyl]-2-yl]carbonyl]-, methyl ester
- L-Methionine, N-[[5-[(2-amino-3-mercaptopropyl)amino][1,1′-biphenyl]-2-yl]carbonyl]-, methyl ester, (R)-
- FTI 277
FTI-277 is a novel small molecule that binds to the P2Y receptor on tumor cells, which prevents ATP from binding and activating the receptor. It has been shown to inhibit the mitochondrial membrane potential and induce apoptosis in HL-60 cells and K562 cells. FTI-277 also inhibits HIV infection in vivo. The drug is not toxic to normal cells, suggesting that it may be an effective chemotherapeutic agent for treatment of cancer and HIV infection.
Proprietà chimiche
Richiesta tecnica su: 3D-VGA00673 FTI-277 trifluoroacetate salt
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.